The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice

Bibliographic Details
Main Authors:	Sandborn, W, Colombel, J, D'Haens, G, Ghosh, S, Panaccione, R, Panés, J, Travis, S, Peyrin-Biroulet, L
Format:	Journal article
Language:	English
Published:	AGA Institute 2016

Similar Items

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
by: Vuitton, L, et al.
Published: (2017)

Review article: defining remission in ulcerative colitis.
by: Travis, S, et al.
Published: (2011)

Ulcerative colitis and Crohn's disease--susceptibility genes and clinical patterns.
by: Jewell, D
Published: (1998)

Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative
by: Danese, S, et al.
Published: (2015)

Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
by: Travis, S, et al.
Published: (2017)

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
by: Sandborn, W, et al.
Published: (2015)

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA
by: Travis, S, et al.
Published: (2017)

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results From InspirADA.
by: Travis, S, et al.
Published: (2017)

Review article: insurance risks for patients with ulcerative colitis or Crohn's disease.
by: Travis, S
Published: (1997)

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
by: Peyrin-Biroulet, L, et al.
Published: (2012)

European evidence-based Consensus on the management of ulcerative colitis: Current management.
by: Travis, S, et al.
Published: (2008)

Immune complexes in ulcerative colitis and Crohn's disease.
by: Hodgson, H, et al.
Published: (1977)

Aetiology and pathogenesis of ulcerative colitis and Crohn's disease.
by: Jewell, D
Published: (1989)

Corticosteroids for the management of ulcerative colitis and Crohn's disease.
by: Jewell, D
Published: (1989)

Clq metabolism in ulcerative colitis and Crohn's disease.
by: Potter, B, et al.
Published: (1979)

Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
by: Travis, S, et al.
Published: (2017)

Placebo response and remission rates in Ulcerative Colitis clinical trials: Systematic review and meta-analysis
by: Jairath, V, et al.
Published: (2015)

Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn’s Disease Phenotypes
by: Taleban, Sasha, et al.
Published: (2017)

Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers.
by: Travis, S, et al.
Published: (2011)

The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.
by: Van Assche, G, et al.
Published: (2011)

Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
by: Sandborn, W, et al.
Published: (2001)

Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
by: Potter, B, et al.
Published: (1980)

C3 metabolism in ulcerative colitis and Crohn's disease.
by: Hodgson, H, et al.
Published: (1977)

Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis.
by: Rhodes, J, et al.
Published: (1983)

Circulating immune complexes in ulcerative colitis and Crohn's disease.
by: Jewell, D, et al.
Published: (1972)

Impact of bowel urgency on quality of life and clinical outcomes in patients with ulcerative colitis
by: Dubinsky, MC, et al.
Published: (2022)

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
by: D'Haens, G, et al.
Published: (2009)

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation.
by: Cooney, R, et al.
Published: (2007)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
by: Travis, S, et al.
Published: (2012)

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
by: Travis, S, et al.
Published: (2015)

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
by: Lichtenstein, G, et al.
Published: (2015)

The new steroids: clinical experience in ulcerative colitis.
by: Jewell, D
Published: (1990)

Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
by: Rhodes, J, et al.
Published: (1982)

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM
by: Reinisch, W, et al.
Published: (2018)

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.
by: Mahadevan, U, et al.
Published: (2011)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
by: Travis, S, et al.
Published: (2014)

Risk factors for low BMD in patients with Crohn's disease and ulcerative colitis
by: McCrudden, R, et al.
Published: (2001)

Risk factors for low BMD in patients with Crohn's disease and ulcerative colitis.
by: McCrudden, R, et al.
Published: (2000)

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
by: Travis, S, et al.
Published: (2013)

Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group.
by: Travis, S, et al.
Published: (1997)